Immunohistochemical correlation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-2 in tobacco associated epithelial dysplasia

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Bajracharya, Dipshikha ^a   Shrestha, Bijayatha ^a   Kamath, Asha ^b   Menon, Aparna ^c   Radhakrishnan, Raghu ^c  

^a Manipal Group of Hospitals   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c MANIPAL COLLEGE OF DENTAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TOBACCO SMOKE; MMP2 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CHEEK MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KRUSKAL WALLIS TEST; LEUKOPLAKIA; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; RETROSPECTIVE STUDY; SCORING SYSTEM; SMOKING; TUMOR GROWTH; DISEASE COURSE; ENZYMOLOGY; FEMALE; LEUKOPLAKIA, ORAL; METABOLISM; MOUTH MUCOSA; PATHOLOGY;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MOUTH MUCOSA; RETROSPECTIVE STUDIES; SMOKING; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84897013586     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/197813     Document Type: Article

References (33)

1. Silverman S. Jr., Gorsky M., Lozada F., Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984 53 3 563 568 2-s2.0-0021327586
2. Gupta P. C., Mehta F. S., Daftary D. K., Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dentistry and Oral Epidemiology 1980 8 6 287 333 2-s2.0-0019131801
3. Parsons S. L., Watson S. A., Brown P. D., Collins H. M., Steele R. J. C., Matrix metalloproteinases. British Journal of Surgery 1997 84 2 160 166 2-s2.0-0031026874 10.1002/bjs.1800840206
4. Peng Z.-H., Wan D.-S., Li L.-R., Chen G., Lu Z.-H., Wu X.-J., Kong L.-H., Pan Z.-Z., Expression of COX-2, MMP-2 and VEGF in stage II and III colorectal cancer and the clinical significance. Hepato-Gastroenterology 2011 58 106 369 376 2-s2.0-79958081178
5. Park S., Kim E.-S., Noh D.-Y., Hwang K.-T., Moon A., H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2. Cytokine 2011 55 1 126 133 2-s2.0-79956340285 10.1016/j.cyto.2011.03.002
6. Li R., Li G., Deng L., Liu Q., Dai J., Shen J., Zhang J., IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncology Reports 2010 23 6 1553 1559 2-s2.0-77951735629 10.3892/or-00000795
7. Vu T. H., Werb Z., Matrix metalloproteinases: effectors of development and normal physiology. Genes and Development 2000 14 17 2123 2133 2-s2.0-0033848986 10.1101/gad.815400
8. Woessner J. F. Jr., MMPS and TIMPS2-an historical perspective. Applied Biochemistry and Biotechnology Part B 2002 22 1 33 49 2-s2.0-0036728623
9. Sorsa T., Tjäderhane L., Salo T., Matrix metalloproteinases (MMPs) in oral diseases. Oral Diseases 2004 10 6 311 318 2-s2.0-9444232274 10.1111/j.1601-0825.2004.01038.x
10. Määttä M., Santala M., Soini Y., Turpeenniemi-Hujanen T., Talvensaari-Mattila A., Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma. Acta Obstetricia et Gynecologica Scandinavica 2010 89 3 380 384 2-s2.0-77749337518 10.3109/00016340903555990
11. Lumerman H., Freedman P., Kerpel S., Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and 1995 79 3 321 329 2-s2.0-0029261756
12. Gaiotto M. A. M., Focchi J., Ribalta J. L. C., Stávale J. N., Baracat E. C., Lima G. R., Guerreiro Da Silva I. D. C., Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma. American Journal of Obstetrics and Gynecology 2004 190 5 1278 1282 2-s2.0-2542471332 10.1016/j.ajog.2003.12.017
13. Ruokolainen H., Pääkkö P., Turpeenniemi-Hujanen T., Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma-tissue immunoreactivity predicts aggressive clinical course. Modern Pathology 2006 19 2 208 217 2-s2.0-30944455693 10.1038/modpathol.3800506
14. Califano J., Van Der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., Sidransky D., Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research 1996 56 11 2488 2492 2-s2.0-9344247476
15. Tsantoulis P. K., Kastrinakis N. G., Tourvas A. D., Laskaris G., Gorgoulis V. G., Advances in the biology of oral cancer. Oral Oncology 2007 43 6 523 534 2-s2.0-34249844797 10.1016/j.oraloncology.2006.11.010
16. Sutinen M., Kainulainen T., Hurskainen T., Vesterlund E., Alexander J. P., Overall C. M., Sorsa T., Salo T., Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. British Journal of Cancer 1998 77 12 2239 2245 2-s2.0-0031800115
17. Sarioǧlu S., Özer E., Kirimca F., Sis B., Pabuçcuoǧlu U., Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathology Research and Practice 2001 197 7 483 486 2-s2.0-0034920180
18. Huhtala P., Tuuttila A., Chow L. T., Lohi J., Keski-Oja J., Tryggvason K., Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. Journal of Biological Chemistry 1991 266 25 16485 16490 2-s2.0-0025952928
19. Ko K., Yazumi S., Yoshikawa K., Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact co-cultures. International Journal of Cancer 2000 87 165 171
20. Roomi M. W., Monterrey J. C., Kalinovsky T., Rath M., Niedzwiecki A., Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncology Reports 2009 21 5 1323 1333 2-s2.0-67649336792 10.3892/or-00000358
21. Gao Z.-B., Duan Y.-Q., Zhang L., Chen D.-W., Ding P.-T., Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. International Journal of Molecular Medicine 2005 16 4 599 603 2-s2.0-33644665252
22. Robinson C. M., Stone A. M., Shields J. D., Huntley S., Paterson I. C., Prime S. S., Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Archives of Oral Biology 2003 48 11 779 786 2-s2.0-0142126669 10.1016/S0003-9969(03)00172-9
23. Zucker S., Conner C., DiMassmo B. I., Ende H., Drews M., Seiki M., Bahou W. F., Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. Journal of Biological Chemistry 1995 270 40 23730 23738 2-s2.0-0028804964 10.1074/jbc.270.40.23730
24. Unemori E. N., Bouhana K. S., Werb Z., Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. Journal of Biological Chemistry 1990 265 1 445 451 2-s2.0-0025139833
25. Hong S.-D., Hong S.-P., Lee J.-I., Lim C.-Y., Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncology 2000 36 2 207 213 2-s2.0-0034162024 10.1016/S1368-8375(99)00088-3
26. Qin H., Sun Y., Benveniste E. N., The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. Journal of Biological Chemistry 1999 274 41 29130 29137 2-s2.0-0032857460 10.1074/jbc.274.41.29130
27. Ruiz M., Troncoso P., Bruns C., Bar-Eli M., Activator protein 2 α transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Clinical Cancer Research 2001 7 12 4086 4095 2-s2.0-0035542952
28. Saranath D., Chang S. E., Bhoite L. T., Panchal R. G., Kerr I. B., Mehta A. R., Johnson N. W., Deo M. G., High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. British Journal of Cancer 1991 63 4 573 578 2-s2.0-0025732716
29. Liao J., Wolfman J. C., Wolfman A., K-Ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts. Journal of Biological Chemistry 2003 278 34 31871 31878 2-s2.0-0041856164 10.1074/jbc.M301931200
30. Katayama A., Bandoh N., Kishibe K., Takahara M., Ogino T., Nonaka S., Harabuchi Y., Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clinical Cancer Research 2004 10 2 634 640 2-s2.0-0842311599 10.1158/1078-0432.CCR-0864-02
31. Karagiannis E. D., Popel A. S., A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. Journal of Biological Chemistry 2004 279 37 39105 39114 2-s2.0-4644236059 10.1074/jbc.M403627200
32. Lu K. V., Jong K. A., Rajasekaran A. K., Cloughesy T. F., Mischel P. S., Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Laboratory Investigation 2004 84 1 8 20 2-s2.0-1542781585 10.1038/sj.labinvest.3700003
33. Li B.-H., Zhao P., Liu S.-Z., Yu Y.-M., Han M., Wen J.-K., Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis. World Journal of Gastroenterology 2005 11 20 3046 3050 2-s2.0-20344407104